Most recent by Lisa K. Lohr, PharmD, BCPS, BCOP
Dexamethasone can provide short-term relief from cancer-related fatigue
Cancer-related fatigue is one of the most distressing symptoms reported by patients with cancer.
Chemotherapy agents, corticosteroids associated with hyperglycemia
There is a significant overlap of patients with coexisting cancer and diabetes.
Prevention, treatment of herpes zoster pose challenges for patients with cancer
Herpes zoster is the manifestation of reactivated latent varicella zoster virus in the sensory ganglia.
Prevention treatment of herpes zoster pose challenges for patients with cancer
Herpes zoster is the manifestation of reactivated latent varicella zoster virus in the sensory ganglia.
Ponatinib: Another new treatment for CML
It is remarkable that, in the past year, the FDA approved three new agents to treat patients with chronic myeloid leukemia.
Memantine may help prevent cognitive decline after brain radiation
Cognitive decline is one of the potential adverse effects of cranial radiation therapy in cancer patients.
Bosutinib: Another option for the treatment of CML
There are three tyrosine kinase inhibitors available for the treatment of chronic myeloid leukemia, but some patients cannot tolerate the side effects.
TKI-induced hypothyroidism common, but exact causes remain unclear
Tyrosine kinase inhibitors frequently cause adverse effects that are different from those caused by classical antineoplastic agents.
Hypertension associated with VEGF inhibitors must be detected, treated
Hypertension is a common adverse effect of chemotherapy agents that inhibit the vascular endothelial growth factor signaling pathway.
Calcium and magnesium supplementation may reduce oxaliplatin-induced neurotoxicity
Oxaliplatin is predominantly used in the treatment of colorectal cancer, both in the adjuvant setting and in treatment of metastatic disease.